Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Gibco™ CTS™ DynaXS™ Single Use Bioreactor, a purpose-built expansion platform designed to help cell therapy ...

At the 2024 annual meeting of the International Society for Cell & Gene Therapy (ISCT) in Vancouver, Canada, Hélio Tomás, PhD, senior research associate at the Instituto de Biologia Experimental e ...

The application makes the power of AI accessible to pharma manufacturing while preserving GxP compliance, enabling data-driven decisions faster in the pursuit of bioreactor process optimization.

Bioreactor makers should consider using additive manufacturing, also known as 3D printing, according to a study, which suggests the potential benefits of the approach would be worth the investment.

BETHLEHEM, Pa.--(BUSINESS WIRE)--ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing, today announced that Emergent BioSolutions will equip their Baltimore ...

Thermo Fisher launched a single-use bioreactor designed to support scalable, flexible, and cGMP-ready cell therapy ...

Technological innovations throughout the past several decades have transformed the pharmaceutical manufacturing process from traditional batch production to ...